[1] |
MILEVA N, NAGUMO S, MIZUKAMI T,et al. Prevalence of coronary microvascular disease and coronary vasospasm in patients with nonobstructive coronary artery disease:systematic review and meta-analysis[J]. J Am Heart Assoc, 2022, 11(7):e023207. DOI: 10.1161/JAHA.121.023207.
|
[2] |
KELSHIKER M A, SELIGMAN H, HOWARD J P,et al. Coronary flow reserve and cardiovascular outcomes:a systematic review and meta-analysis[J]. Eur Heart J, 2022, 43(16):1582-1593. DOI: 10.1093/eurheartj/ehab775.
|
[3] |
JOHNSON N P, GOULD K L, DI CARLI M F,et al. Invasive FFR and noninvasive CFR intheEvaluation of ischemia:what is the future?[J]. J Am Coll Cardiol, 2016, 67(23):2772-2788. DOI: 10.1016/j.jacc.2016.03.584.
|
[4] |
TAQUETI V R, DI CARLI M F. Coronary microvascular disease pathogenic mechanisms and therapeutic options:JACC state-of-the-art review[J]. J Am Coll Cardiol, 2018, 72(21):2625-2641. DOI: 10.1016/j.jacc.2018.09.042.
|
[5] |
MICHELSEN M M, PENA A, MYGIND N D,et al. Coronary flow velocity reserve assessed by transthoracic Doppler:the iPOWER study:factors influencing feasibility and quality[J]. J Am Soc Echocardiogr, 2016, 29(7):709-716. DOI: 10.1016/j.echo.2016.02.011.
|
[6] |
MANABE O, NAYA M, TAMAKI N. Feasibility of PET for the management of coronary artery disease:comparison between CFR and FFR[J]. J Cardiol, 2017, 70(2):135-140. DOI: 10.1016/j.jjcc.2017.03.002.
|
[7] |
KRAKOVICH A, GELBART E, MOALEM I,et al. Dose-consistent dynamic SPECT[J]. J Nucl Cardiol,2022,30(4):1341-1351.
|
[8] |
SINHA A, RAHMAN H, PERERA D. Ischaemia without obstructive coronary artery disease:the pathophysiology of microvascular dysfunction[J]. Curr Opin Cardiol, 2020, 35(6):720-725. DOI: 10.1097/HCO.0000000000000788.
|
[9] |
|
[10] |
GARCÍA-BAIZÁN A, MILLOR M, BARTOLOMÉ P,et al. Adenosine triphosphate (ATP) and adenosine cause similar vasodilator effect in patients undergoing stress perfusion cardiac magnetic resonance imaging[J]. Int J Cardiovasc Imaging, 2019, 35(4):675-682. DOI: 10.1007/s10554-018-1494-y.
|
[11] |
|
[12] |
|
[13] |
SANTOS-PARDO I, ALSTRÖM P, WITT N. Index of microcirculatory resistance measured during intracoronary adenosine-induced hyperemia[J]. J Interv Cardiol, 2020, 2020:4829647. DOI: 10.1155/2020/4829647.
|
[14] |
BURNSTOCK G. Introduction to purinergic signalling in the brain[M]//BARAŃSKA J. Glioma Signaling. Dordrecht:Springer,2013.
|
[15] |
TERWOORD J D, RACINE M L, HEARON C M Jr,et al. ATP and acetylcholine interact to modulate vascular tone and α1-adrenergic vasoconstriction in humans[J]. J Appl Physiol, 2021, 131(2):566-574. DOI: 10.1152/japplphysiol.00205.2021.
|
[16] |
ROMAN R M, FITZ J G. Emerging roles of purinergic signaling in gastrointestinal epithelial secretion and hepatobiliary function[J]. Gastroenterology, 1999, 116(4):964-979. DOI: 10.1016/s0016-5085(99)70081-8.
|
[17] |
HE M L, GONZALEZ-IGLESIAS A E, STOJILKOVIC S S. Role of nucleotide P2 receptors in calcium signaling and prolactin release in pituitary lactotrophs[J]. J Biol Chem, 2003, 278(47):46270-46277. DOI: 10.1074/jbc.M309005200.
|
[18] |
WANG C J, GENG B, CUI Q H,et al. Intracellular and extracellular adenosine triphosphate in regulation of insulin secretion from pancreatic β cells (β)[J]. J Diabetes, 2014, 6(2):113-119. DOI: 10.1111/1753-0407.12098.
|
[19] |
王国栋,马青变,胡振春.探讨三磷酸腺苷治疗阵发性室上性心动过速的有效剂量及安全性[J].临床医药文献电子杂志,2015,2(31):6440-6441.
|